| abstract |
This invention concerns a novel tablet pharmaceutical composition, used for the treatment hyperlipoproteinemia, hypercholesterolaemia and atherosclerosis. The composition related to this invention comprises amorphous rosuvastatin calcium, stabilized by adding calcium carbonate in a ratio of 0,5...2:1 (w/w) and other excipients: 30...60% lactose monohydrate, 15...35% microcrystalline cellulose, 1...5% crospovidone and 0,25...5% magnesium stearate. |